<DOC>
	<DOCNO>NCT00212407</DOCNO>
	<brief_summary>Umbilical cord blood use source hematopoietic stem cell bone marrow reconstitution patient would potential candidate bone marrow transplant unrelated marrow donor . The outcome transplantation obtain assess cord blood myeloid platelet engraftment , transplant related mortality , overall survival , graft vs. host disease , patient leukemia , lymphoma myelodysplasia , relapse .</brief_summary>
	<brief_title>New York Blood Center National Cord Blood Program</brief_title>
	<detailed_description>Umbilical cord blood donate New York Blood Center 's National Cord Blood Program collect , test , process , cryoprotected frozen liquid nitrogen possible future transplantation anyone need . The Program operate FDA IND exemption since 1996 license tissue bank New York State Department Health . Candidates transplant patient disease require bone marrow transplantation suitable related bone marrow donor . Most patient high risk refractory leukemia , lymphoma , myelodysplasia , severe aplastic anemia certain genetic hematologic , immunologic metabolic disease . Patients treat bone marrow transplant center United States country active marrow transplant program . Because NYBC Program operate IND , patient must sign informed consent cord blood transplantation . Transplant center report transplant procedure ( include immediate complication ) transplant outcome 3 , 6 12 month post-transplant annually thereafter . Data report New York Blood Center include information patient 's disease pre-transplant condition regimen post-transplant endpoint , primarily myeloid platelet engraftment , transplant related mortality , overall survival , acute chronic graft vs. host disease , relapse post-transplant complication infectious disease . The outcome data use assess safety efficacy use apply license FDA .</detailed_description>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Candidates bone marrow transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cord blood transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
</DOC>